Seattle Genetics

Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Data in CD30-Positive Non-Hodgkin Lymphomas and Other Malignancies from Multiple Presentations at ASH Annual Meeting
Yahoo/BusinessWire
Sun, 12/9/12 - 01:17 pm
Seattle Genetics
Adcetris
non-Hodgkin's lymphoma
Seattle Genetics: A Short Thesis That's Been Right And Wrong
TheStreet.com
Mon, 11/12/12 - 11:41 am
Seattle Genetics
3 Things to Watch With Seattle Genetics
Motley Fool
Sat, 11/3/12 - 11:24 am
Seattle Genetics
3 Things to Watch With Celldex Therapeutics
Motley Fool
Thu, 10/4/12 - 10:52 am
Celldex
rindopepimut
CDX-011
Pfizer
Bristol-Myers Squibb
Amgen
Seattle Genetics
AstraZeneca Suspends The Buyback: Let The M&A Speculation Commence
Seekin Alpha
Mon, 10/1/12 - 09:52 pm
M&A
AstraZeneca
Seattle Genetics
Regeneron
ONYX Pharmaceuticals
Biomarin
Forest Labs
PDL BioPharma CEO Explains Strategy To Maintain Dividend With Significant Growth
Seeking Alpha
Tue, 09/18/12 - 11:09 am
PDL Biopharma
Novartis
Seattle Genetics
Pfizer
JNJ
Eli Lilly
GSK
Bristol-Myers Squibb
2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com
Tue, 08/28/12 - 11:07 am
Cell Therapeutics
Momenta
Onyx
Amag Pharmaceuticals
Biomarin
M&A
Celgene
Seattle Genetics
Galena Biopharma
ImmunoCellular
Amgen
Celldex
Dendreon
GSK
Vical
Oncothyreon
Biogen Idec
Merck KGaA
Bristol-Myers Squibb
Allos
Spectrum Pharmaceuticals
AstraZeneca
Six Disruptive Biotech Stocks
Motley Fool
Sat, 08/18/12 - 03:51 pm
Dendreon
Seattle Genetics
Immunogen
Roche
Vertex Pharmaceuticals
Aveo
Ariad Pharmaceuticals
Isis Pharmaceuticals
A Growth-Free Quarter -- and That's OK
Motley Fool
Sat, 08/11/12 - 12:11 pm
Seattle Genetics
Seattle Genetics: A Growth-Free Quarter -- and That's OK
Motley Fool
Fri, 08/10/12 - 06:22 pm
Seattle Genetics
earnings
Bio Buyouts
Motley Fool
Sun, 07/29/12 - 12:10 pm
Seattle Genetics
Alexion
Regeneron
Biomarin
Vertex Pharmaceuticals
Idenix
Obagi Medical Products
6 Biotech Stocks That Analysts Give The Green Light
Seeking Alpha
Fri, 07/27/12 - 12:05 pm
GTx
Illumina
InterMune
QLT
Seattle Genetics
Vivus
Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers
Seeking Alpha
Sun, 07/15/12 - 11:22 am
Alkermes
Medivation
Cubist Pharmaceuticals
Ariad Pharmaceuticals
Questcor Pharmaceuticals
Arena Pharmaceuticals
Seattle Genetics
Incyte
United Therapeutics
Amarin
ONYX Pharmaceuticals
Pharmacyclics
Human Genome Sciences
Theravance
Seattle Genetics CEO Says Drug Growth Path Means No Sale
Bloomberg
Fri, 07/13/12 - 01:29 pm
Seattle Genetics
M&A
Pharma CEOs
Clay Siegall
Seattle Genetics CEO Siegall Sees Many Uses for Cancer Drug
Minyanville
Fri, 06/15/12 - 11:05 am
Seattle Genetics
Clay Siegall
Adcetris
Seattle Genetics updates survival data from Adcetris trial for Hodkin lymphoma
Yahoo/Fly on the Wall
Thu, 06/14/12 - 11:14 am
Seattle Genetics
Adcetris
Hodgkin's lymphoma
How High Can Seattle Genetics Fly?
Motley Fool
Tue, 06/12/12 - 10:54 am
Seattle Genetics
antibody-drug conjugate
Winners Of ASCO 2012
Seeking Alpha
Mon, 06/11/12 - 06:19 pm
ASCO
Arqule
Array Biopharma
Astex
AstraZeneca
Bristol-Myers Squibb
GSK
Curis
Exelixis
Pfizer
Immunogen
Seattle Genetics
Sanofi
Synta
Seattle Genetics Shares Continue To Impress - And It's Not Too Late To Buy
Seeking Alpha
Mon, 06/11/12 - 01:05 pm
Seattle Genetics
ASCO spotlight: Antibody-drug conjugates arrive
Fierce Biotech
Fri, 06/1/12 - 12:28 pm
ASCO
antibody-drug conjugate
Roche
Genentech
Immunogen
T-DM1
Adcetris
Seattle Genetics

Pages